Major Companies in the Taiwan Peripheral Neuropathy Market | Insights & Key Players 2026

Taiwan Peripheral Neuropathy Market Overview

According to 6Wresearch, the Taiwan Peripheral Neuropathy Market is poised for significant expansion, driven by a rapidly aging population and an increasing prevalence of metabolic syndromes. The rising cases of diabetic peripheral neuropathy is boosting the demand for a diverse range of pharmacological interventions. Furthermore, improved healthcare infrastructure, along with consumer awareness about nerve health is strengthening the innovation of advanced therapies, including non-invasive nerve stimulation and next-generation pain management solutions.

Competitive Landscape

The competitive landscape of the Taiwan peripheral neuropathy industry is defined by continuous investment in biotechnology and strategic global partnerships. Leading brands are focused on innovating novel drug delivery systems and biologics. The market is highly competitive as key players strive to offer a comprehensive portfolio that spans from nerve supplements to advanced prescription-grade anaesthetics.

Below is a list of leading players operating in the Taiwan Peripheral Neuropathy Market:

1. Viatris Taiwan

Viatris is a dominant leader in pain management, providing Lyrica, which is essential for treating neuropathic pain in diabetic patients.

2. Pfizer Taiwan

Pfizer maintains a strong presence with its established legacy portfolio, focusing on clinical advancements and localized post-marketing surveillance.

3. Lotus Pharmaceutical

Lotus is a local powerhouse known for its R&D in sustained-release technologies, offering high-quality generic formulations that improve patient compliance.

4. TTY Biopharm

TTY Biopharm contributes to the market with a robust portfolio of neuroprotective agents and specialized treatments for symptoms related to nerve damage.

5. Orient EuroPharma (OEP)

OEP specializes in combination therapies and advanced drug delivery systems that address various chronic neuropathic conditions.

6. Standard Chem & Pharm

Standard Chem & Pharm focuses on innovative biological treatments and supportive over-the-counter nerve health solutions that cater to the aging population.

7. U-Pharma

U-Pharma is a key contributor in the CNS field, developing therapies for neurological disorders and localized pain management.

8. Yung Shin Pharmaceutical (YSP)

YSP contributes to the market with its established portfolio of metabolic disease medications, which manage the underlying causes of diabetic neuropathy.

9. Eisai Taiwan

Eisai Taiwan is highly specialized in neurology, providing Methycobal for the treatment of peripheral neuropathies.

10. AstraZeneca Taiwan

AstraZeneca Taiwan provides specialized treatments for underlying metabolic and inflammatory pathways that contribute to severe peripheral nerve complications.